Scientists from Harvard labs have announced significant progress in the treatment of diabetes involving the re - programming of lower stomach cells to function as insulin - producing beta - like cells , although the frequent use of insulin injections could be avoided in certain cases . Although researchers have yet to discover a method to apply results directly from genetically engineered mice to the human body , it is believed that such processes will allow physicians to develop patient - specific treatments by growing and reproducing insulin - releasing cells from biopsy samples .
Scientists from Harvard University have announced significant progress in the treatment of diabetes involving the re-programming of lower stomach cells to act as insulin-producing beta-like cells, meaning the frequent use of insulin injections could be avoided in certain cases. Although researchers have yet to discover a method to apply results yielded from genetically engineered mice to the human body, it is believed that such processes will allow physicians to conduct patient-specific treatments by growing and reproducing insulin-releasing cells from biopsy samples.